nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Imiquimod—skin cancer	0.246	0.375	CbGbCtD
Betaxolol—CYP1A2—Vemurafenib—skin cancer	0.135	0.206	CbGbCtD
Betaxolol—CYP2D6—Vemurafenib—skin cancer	0.111	0.169	CbGbCtD
Betaxolol—CYP1A2—Dacarbazine—skin cancer	0.103	0.158	CbGbCtD
Betaxolol—CYP1A2—Fluorouracil—skin cancer	0.0605	0.0924	CbGbCtD
Betaxolol—Sinusitis—Fluorouracil—skin cancer	0.000485	0.00141	CcSEcCtD
Betaxolol—Erythema—Dactinomycin—skin cancer	0.000485	0.00141	CcSEcCtD
Betaxolol—Agranulocytosis—Fluorouracil—skin cancer	0.000483	0.0014	CcSEcCtD
Betaxolol—Ill-defined disorder—Bleomycin—skin cancer	0.000483	0.0014	CcSEcCtD
Betaxolol—Anaemia—Bleomycin—skin cancer	0.000481	0.00139	CcSEcCtD
Betaxolol—Diarrhoea—Vemurafenib—skin cancer	0.000479	0.00139	CcSEcCtD
Betaxolol—Urticaria—Imiquimod—skin cancer	0.000475	0.00138	CcSEcCtD
Betaxolol—Body temperature increased—Imiquimod—skin cancer	0.000472	0.00137	CcSEcCtD
Betaxolol—Eye disorder—Temozolomide—skin cancer	0.000471	0.00137	CcSEcCtD
Betaxolol—Tinnitus—Temozolomide—skin cancer	0.00047	0.00136	CcSEcCtD
Betaxolol—Malaise—Bleomycin—skin cancer	0.000469	0.00136	CcSEcCtD
Betaxolol—Flushing—Temozolomide—skin cancer	0.000468	0.00136	CcSEcCtD
Betaxolol—Cardiac disorder—Temozolomide—skin cancer	0.000468	0.00136	CcSEcCtD
Betaxolol—Rhinitis—Fluorouracil—skin cancer	0.000466	0.00135	CcSEcCtD
Betaxolol—Dizziness—Vemurafenib—skin cancer	0.000463	0.00134	CcSEcCtD
Betaxolol—Hypoaesthesia—Fluorouracil—skin cancer	0.000462	0.00134	CcSEcCtD
Betaxolol—Pharyngitis—Fluorouracil—skin cancer	0.000461	0.00134	CcSEcCtD
Betaxolol—Angiopathy—Temozolomide—skin cancer	0.000457	0.00133	CcSEcCtD
Betaxolol—Ataxia—Docetaxel—skin cancer	0.000456	0.00132	CcSEcCtD
Betaxolol—Immune system disorder—Temozolomide—skin cancer	0.000455	0.00132	CcSEcCtD
Betaxolol—Mediastinal disorder—Temozolomide—skin cancer	0.000454	0.00132	CcSEcCtD
Betaxolol—Cough—Bleomycin—skin cancer	0.000454	0.00132	CcSEcCtD
Betaxolol—Chills—Temozolomide—skin cancer	0.000452	0.00131	CcSEcCtD
Betaxolol—Ill-defined disorder—Dactinomycin—skin cancer	0.00045	0.0013	CcSEcCtD
Betaxolol—Anaemia—Dactinomycin—skin cancer	0.000448	0.0013	CcSEcCtD
Betaxolol—Vomiting—Vemurafenib—skin cancer	0.000445	0.00129	CcSEcCtD
Betaxolol—Alopecia—Temozolomide—skin cancer	0.000445	0.00129	CcSEcCtD
Betaxolol—Chest pain—Bleomycin—skin cancer	0.000443	0.00128	CcSEcCtD
Betaxolol—Myalgia—Bleomycin—skin cancer	0.000443	0.00128	CcSEcCtD
Betaxolol—Rash—Vemurafenib—skin cancer	0.000442	0.00128	CcSEcCtD
Betaxolol—Mental disorder—Temozolomide—skin cancer	0.000442	0.00128	CcSEcCtD
Betaxolol—Dermatitis—Vemurafenib—skin cancer	0.000441	0.00128	CcSEcCtD
Betaxolol—Hypersensitivity—Imiquimod—skin cancer	0.00044	0.00128	CcSEcCtD
Betaxolol—Headache—Vemurafenib—skin cancer	0.000439	0.00127	CcSEcCtD
Betaxolol—Erythema—Temozolomide—skin cancer	0.000439	0.00127	CcSEcCtD
Betaxolol—Malnutrition—Temozolomide—skin cancer	0.000439	0.00127	CcSEcCtD
Betaxolol—Breast disorder—Docetaxel—skin cancer	0.000438	0.00127	CcSEcCtD
Betaxolol—Discomfort—Bleomycin—skin cancer	0.000437	0.00127	CcSEcCtD
Betaxolol—Malaise—Dactinomycin—skin cancer	0.000437	0.00127	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000436	0.00126	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000436	0.00126	CcSEcCtD
Betaxolol—Cramp muscle—Docetaxel—skin cancer	0.000436	0.00126	CcSEcCtD
Betaxolol—Nasopharyngitis—Docetaxel—skin cancer	0.000433	0.00126	CcSEcCtD
Betaxolol—Dysgeusia—Temozolomide—skin cancer	0.00043	0.00125	CcSEcCtD
Betaxolol—Asthenia—Imiquimod—skin cancer	0.000429	0.00124	CcSEcCtD
Betaxolol—Confusional state—Bleomycin—skin cancer	0.000428	0.00124	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000427	0.00124	CcSEcCtD
Betaxolol—Oedema—Bleomycin—skin cancer	0.000424	0.00123	CcSEcCtD
Betaxolol—Pruritus—Imiquimod—skin cancer	0.000423	0.00123	CcSEcCtD
Betaxolol—Infection—Bleomycin—skin cancer	0.000422	0.00122	CcSEcCtD
Betaxolol—Dysphagia—Docetaxel—skin cancer	0.000419	0.00121	CcSEcCtD
Betaxolol—Nausea—Vemurafenib—skin cancer	0.000416	0.00121	CcSEcCtD
Betaxolol—Thrombocytopenia—Bleomycin—skin cancer	0.000416	0.0012	CcSEcCtD
Betaxolol—Arrhythmia—Fluorouracil—skin cancer	0.000415	0.0012	CcSEcCtD
Betaxolol—Vision blurred—Temozolomide—skin cancer	0.000413	0.0012	CcSEcCtD
Betaxolol—Myalgia—Dactinomycin—skin cancer	0.000413	0.0012	CcSEcCtD
Betaxolol—Bronchospasm—Docetaxel—skin cancer	0.000412	0.00119	CcSEcCtD
Betaxolol—Tremor—Temozolomide—skin cancer	0.000411	0.00119	CcSEcCtD
Betaxolol—Alopecia—Fluorouracil—skin cancer	0.00041	0.00119	CcSEcCtD
Betaxolol—Diarrhoea—Imiquimod—skin cancer	0.000409	0.00119	CcSEcCtD
Betaxolol—Discomfort—Dactinomycin—skin cancer	0.000408	0.00118	CcSEcCtD
Betaxolol—Angina pectoris—Docetaxel—skin cancer	0.000408	0.00118	CcSEcCtD
Betaxolol—Ill-defined disorder—Temozolomide—skin cancer	0.000407	0.00118	CcSEcCtD
Betaxolol—Anaemia—Temozolomide—skin cancer	0.000405	0.00118	CcSEcCtD
Betaxolol—Anorexia—Bleomycin—skin cancer	0.000405	0.00117	CcSEcCtD
Betaxolol—Erythema—Fluorouracil—skin cancer	0.000404	0.00117	CcSEcCtD
Betaxolol—Hypotension—Bleomycin—skin cancer	0.000397	0.00115	CcSEcCtD
Betaxolol—Oedema—Dactinomycin—skin cancer	0.000396	0.00115	CcSEcCtD
Betaxolol—Malaise—Temozolomide—skin cancer	0.000396	0.00115	CcSEcCtD
Betaxolol—Dizziness—Imiquimod—skin cancer	0.000395	0.00115	CcSEcCtD
Betaxolol—Vertigo—Temozolomide—skin cancer	0.000394	0.00114	CcSEcCtD
Betaxolol—Infection—Dactinomycin—skin cancer	0.000393	0.00114	CcSEcCtD
Betaxolol—Palpitations—Temozolomide—skin cancer	0.000388	0.00112	CcSEcCtD
Betaxolol—Thrombocytopenia—Dactinomycin—skin cancer	0.000388	0.00112	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000387	0.00112	CcSEcCtD
Betaxolol—Cough—Temozolomide—skin cancer	0.000383	0.00111	CcSEcCtD
Betaxolol—Paraesthesia—Bleomycin—skin cancer	0.000381	0.00111	CcSEcCtD
Betaxolol—Weight increased—Docetaxel—skin cancer	0.000381	0.0011	CcSEcCtD
Betaxolol—Vision blurred—Fluorouracil—skin cancer	0.000381	0.0011	CcSEcCtD
Betaxolol—Vomiting—Imiquimod—skin cancer	0.00038	0.0011	CcSEcCtD
Betaxolol—Weight decreased—Docetaxel—skin cancer	0.000379	0.0011	CcSEcCtD
Betaxolol—Dyspnoea—Bleomycin—skin cancer	0.000378	0.0011	CcSEcCtD
Betaxolol—Anorexia—Dactinomycin—skin cancer	0.000377	0.00109	CcSEcCtD
Betaxolol—Rash—Imiquimod—skin cancer	0.000377	0.00109	CcSEcCtD
Betaxolol—Dermatitis—Imiquimod—skin cancer	0.000376	0.00109	CcSEcCtD
Betaxolol—Pneumonia—Docetaxel—skin cancer	0.000376	0.00109	CcSEcCtD
Betaxolol—Headache—Imiquimod—skin cancer	0.000374	0.00109	CcSEcCtD
Betaxolol—Anaemia—Fluorouracil—skin cancer	0.000374	0.00108	CcSEcCtD
Betaxolol—Myalgia—Temozolomide—skin cancer	0.000373	0.00108	CcSEcCtD
Betaxolol—Arthralgia—Temozolomide—skin cancer	0.000373	0.00108	CcSEcCtD
Betaxolol—Infestation NOS—Docetaxel—skin cancer	0.000373	0.00108	CcSEcCtD
Betaxolol—Infestation—Docetaxel—skin cancer	0.000373	0.00108	CcSEcCtD
Betaxolol—Anxiety—Temozolomide—skin cancer	0.000372	0.00108	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000371	0.00108	CcSEcCtD
Betaxolol—Discomfort—Temozolomide—skin cancer	0.000369	0.00107	CcSEcCtD
Betaxolol—Decreased appetite—Bleomycin—skin cancer	0.000369	0.00107	CcSEcCtD
Betaxolol—Acute coronary syndrome—Docetaxel—skin cancer	0.000368	0.00107	CcSEcCtD
Betaxolol—Neuropathy peripheral—Docetaxel—skin cancer	0.000366	0.00106	CcSEcCtD
Betaxolol—Myocardial infarction—Docetaxel—skin cancer	0.000366	0.00106	CcSEcCtD
Betaxolol—Dry mouth—Temozolomide—skin cancer	0.000365	0.00106	CcSEcCtD
Betaxolol—Stomatitis—Docetaxel—skin cancer	0.000364	0.00106	CcSEcCtD
Betaxolol—Pain—Bleomycin—skin cancer	0.000363	0.00105	CcSEcCtD
Betaxolol—Conjunctivitis—Docetaxel—skin cancer	0.000363	0.00105	CcSEcCtD
Betaxolol—Confusional state—Temozolomide—skin cancer	0.000361	0.00105	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000361	0.00105	CcSEcCtD
Betaxolol—Oedema—Temozolomide—skin cancer	0.000358	0.00104	CcSEcCtD
Betaxolol—Infection—Temozolomide—skin cancer	0.000356	0.00103	CcSEcCtD
Betaxolol—Nausea—Imiquimod—skin cancer	0.000355	0.00103	CcSEcCtD
Betaxolol—Epistaxis—Docetaxel—skin cancer	0.000352	0.00102	CcSEcCtD
Betaxolol—Nervous system disorder—Temozolomide—skin cancer	0.000351	0.00102	CcSEcCtD
Betaxolol—Thrombocytopenia—Temozolomide—skin cancer	0.000351	0.00102	CcSEcCtD
Betaxolol—Feeling abnormal—Bleomycin—skin cancer	0.00035	0.00101	CcSEcCtD
Betaxolol—Agranulocytosis—Docetaxel—skin cancer	0.000348	0.00101	CcSEcCtD
Betaxolol—Skin disorder—Temozolomide—skin cancer	0.000348	0.00101	CcSEcCtD
Betaxolol—Hyperhidrosis—Temozolomide—skin cancer	0.000346	0.001	CcSEcCtD
Betaxolol—Chest pain—Fluorouracil—skin cancer	0.000344	0.000998	CcSEcCtD
Betaxolol—Myalgia—Fluorouracil—skin cancer	0.000344	0.000998	CcSEcCtD
Betaxolol—Decreased appetite—Dactinomycin—skin cancer	0.000344	0.000998	CcSEcCtD
Betaxolol—Fatigue—Dactinomycin—skin cancer	0.000341	0.00099	CcSEcCtD
Betaxolol—Anorexia—Temozolomide—skin cancer	0.000341	0.00099	CcSEcCtD
Betaxolol—Discomfort—Fluorouracil—skin cancer	0.00034	0.000986	CcSEcCtD
Betaxolol—Pain—Dactinomycin—skin cancer	0.000339	0.000981	CcSEcCtD
Betaxolol—Urticaria—Bleomycin—skin cancer	0.000337	0.000978	CcSEcCtD
Betaxolol—Rhinitis—Docetaxel—skin cancer	0.000336	0.000974	CcSEcCtD
Betaxolol—Body temperature increased—Bleomycin—skin cancer	0.000336	0.000973	CcSEcCtD
Betaxolol—Hypoaesthesia—Docetaxel—skin cancer	0.000333	0.000967	CcSEcCtD
Betaxolol—Confusional state—Fluorouracil—skin cancer	0.000333	0.000964	CcSEcCtD
Betaxolol—Pharyngitis—Docetaxel—skin cancer	0.000333	0.000964	CcSEcCtD
Betaxolol—Oedema—Fluorouracil—skin cancer	0.00033	0.000956	CcSEcCtD
Betaxolol—Infection—Fluorouracil—skin cancer	0.000328	0.00095	CcSEcCtD
Betaxolol—Feeling abnormal—Dactinomycin—skin cancer	0.000326	0.000946	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000326	0.000946	CcSEcCtD
Betaxolol—Insomnia—Temozolomide—skin cancer	0.000324	0.000939	CcSEcCtD
Betaxolol—Nervous system disorder—Fluorouracil—skin cancer	0.000324	0.000938	CcSEcCtD
Betaxolol—Thrombocytopenia—Fluorouracil—skin cancer	0.000323	0.000936	CcSEcCtD
Betaxolol—Visual impairment—Docetaxel—skin cancer	0.000323	0.000936	CcSEcCtD
Betaxolol—Tachycardia—Fluorouracil—skin cancer	0.000322	0.000933	CcSEcCtD
Betaxolol—Paraesthesia—Temozolomide—skin cancer	0.000322	0.000932	CcSEcCtD
Betaxolol—Dyspnoea—Temozolomide—skin cancer	0.000319	0.000925	CcSEcCtD
Betaxolol—Dyspepsia—Temozolomide—skin cancer	0.000315	0.000914	CcSEcCtD
Betaxolol—Anorexia—Fluorouracil—skin cancer	0.000314	0.000912	CcSEcCtD
Betaxolol—Eye disorder—Docetaxel—skin cancer	0.000313	0.000908	CcSEcCtD
Betaxolol—Body temperature increased—Dactinomycin—skin cancer	0.000313	0.000907	CcSEcCtD
Betaxolol—Hypersensitivity—Bleomycin—skin cancer	0.000313	0.000907	CcSEcCtD
Betaxolol—Decreased appetite—Temozolomide—skin cancer	0.000311	0.000902	CcSEcCtD
Betaxolol—Flushing—Docetaxel—skin cancer	0.000311	0.000902	CcSEcCtD
Betaxolol—Cardiac disorder—Docetaxel—skin cancer	0.000311	0.000902	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000309	0.000896	CcSEcCtD
Betaxolol—Fatigue—Temozolomide—skin cancer	0.000309	0.000895	CcSEcCtD
Betaxolol—Hypotension—Fluorouracil—skin cancer	0.000308	0.000894	CcSEcCtD
Betaxolol—Pain—Temozolomide—skin cancer	0.000306	0.000888	CcSEcCtD
Betaxolol—Constipation—Temozolomide—skin cancer	0.000306	0.000888	CcSEcCtD
Betaxolol—Asthenia—Bleomycin—skin cancer	0.000305	0.000883	CcSEcCtD
Betaxolol—Angiopathy—Docetaxel—skin cancer	0.000304	0.000882	CcSEcCtD
Betaxolol—Immune system disorder—Docetaxel—skin cancer	0.000303	0.000878	CcSEcCtD
Betaxolol—Mediastinal disorder—Docetaxel—skin cancer	0.000302	0.000876	CcSEcCtD
Betaxolol—Chills—Docetaxel—skin cancer	0.000301	0.000872	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000301	0.000871	CcSEcCtD
Betaxolol—Pruritus—Bleomycin—skin cancer	0.0003	0.000871	CcSEcCtD
Betaxolol—Arrhythmia—Docetaxel—skin cancer	0.000299	0.000868	CcSEcCtD
Betaxolol—Insomnia—Fluorouracil—skin cancer	0.000298	0.000865	CcSEcCtD
Betaxolol—Paraesthesia—Fluorouracil—skin cancer	0.000296	0.000859	CcSEcCtD
Betaxolol—Alopecia—Docetaxel—skin cancer	0.000296	0.000859	CcSEcCtD
Betaxolol—Feeling abnormal—Temozolomide—skin cancer	0.000295	0.000855	CcSEcCtD
Betaxolol—Dyspnoea—Fluorouracil—skin cancer	0.000294	0.000853	CcSEcCtD
Betaxolol—Mental disorder—Docetaxel—skin cancer	0.000294	0.000851	CcSEcCtD
Betaxolol—Malnutrition—Docetaxel—skin cancer	0.000292	0.000846	CcSEcCtD
Betaxolol—Erythema—Docetaxel—skin cancer	0.000292	0.000846	CcSEcCtD
Betaxolol—Hypersensitivity—Dactinomycin—skin cancer	0.000292	0.000846	CcSEcCtD
Betaxolol—Dyspepsia—Fluorouracil—skin cancer	0.00029	0.000842	CcSEcCtD
Betaxolol—Decreased appetite—Fluorouracil—skin cancer	0.000287	0.000831	CcSEcCtD
Betaxolol—Dysgeusia—Docetaxel—skin cancer	0.000286	0.000828	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000285	0.000826	CcSEcCtD
Betaxolol—Urticaria—Temozolomide—skin cancer	0.000284	0.000825	CcSEcCtD
Betaxolol—Asthenia—Dactinomycin—skin cancer	0.000284	0.000823	CcSEcCtD
Betaxolol—Body temperature increased—Temozolomide—skin cancer	0.000283	0.000821	CcSEcCtD
Betaxolol—Pain—Fluorouracil—skin cancer	0.000282	0.000818	CcSEcCtD
Betaxolol—Muscle spasms—Docetaxel—skin cancer	0.00028	0.000813	CcSEcCtD
Betaxolol—Feeling abnormal—Fluorouracil—skin cancer	0.000272	0.000788	CcSEcCtD
Betaxolol—Diarrhoea—Dactinomycin—skin cancer	0.000271	0.000785	CcSEcCtD
Betaxolol—Vomiting—Bleomycin—skin cancer	0.00027	0.000782	CcSEcCtD
Betaxolol—Anaemia—Docetaxel—skin cancer	0.00027	0.000782	CcSEcCtD
Betaxolol—Rash—Bleomycin—skin cancer	0.000268	0.000776	CcSEcCtD
Betaxolol—Dermatitis—Bleomycin—skin cancer	0.000267	0.000775	CcSEcCtD
Betaxolol—Hypersensitivity—Temozolomide—skin cancer	0.000264	0.000765	CcSEcCtD
Betaxolol—Urticaria—Fluorouracil—skin cancer	0.000262	0.00076	CcSEcCtD
Betaxolol—Syncope—Docetaxel—skin cancer	0.000262	0.000759	CcSEcCtD
Betaxolol—Body temperature increased—Fluorouracil—skin cancer	0.000261	0.000756	CcSEcCtD
Betaxolol—Palpitations—Docetaxel—skin cancer	0.000258	0.000748	CcSEcCtD
Betaxolol—Asthenia—Temozolomide—skin cancer	0.000257	0.000745	CcSEcCtD
Betaxolol—Loss of consciousness—Docetaxel—skin cancer	0.000256	0.000743	CcSEcCtD
Betaxolol—Cough—Docetaxel—skin cancer	0.000255	0.000738	CcSEcCtD
Betaxolol—Pruritus—Temozolomide—skin cancer	0.000253	0.000734	CcSEcCtD
Betaxolol—Nausea—Bleomycin—skin cancer	0.000252	0.000731	CcSEcCtD
Betaxolol—Vomiting—Dactinomycin—skin cancer	0.000252	0.00073	CcSEcCtD
Betaxolol—Rash—Dactinomycin—skin cancer	0.00025	0.000724	CcSEcCtD
Betaxolol—Chest pain—Docetaxel—skin cancer	0.000248	0.00072	CcSEcCtD
Betaxolol—Myalgia—Docetaxel—skin cancer	0.000248	0.00072	CcSEcCtD
Betaxolol—Arthralgia—Docetaxel—skin cancer	0.000248	0.00072	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000247	0.000715	CcSEcCtD
Betaxolol—Diarrhoea—Temozolomide—skin cancer	0.000245	0.00071	CcSEcCtD
Betaxolol—Hypersensitivity—Fluorouracil—skin cancer	0.000243	0.000705	CcSEcCtD
Betaxolol—Dry mouth—Docetaxel—skin cancer	0.000243	0.000704	CcSEcCtD
Betaxolol—Confusional state—Docetaxel—skin cancer	0.00024	0.000696	CcSEcCtD
Betaxolol—Oedema—Docetaxel—skin cancer	0.000238	0.00069	CcSEcCtD
Betaxolol—Dizziness—Temozolomide—skin cancer	0.000237	0.000686	CcSEcCtD
Betaxolol—Infection—Docetaxel—skin cancer	0.000237	0.000686	CcSEcCtD
Betaxolol—Nausea—Dactinomycin—skin cancer	0.000235	0.000682	CcSEcCtD
Betaxolol—Shock—Docetaxel—skin cancer	0.000234	0.000679	CcSEcCtD
Betaxolol—Nervous system disorder—Docetaxel—skin cancer	0.000234	0.000677	CcSEcCtD
Betaxolol—Pruritus—Fluorouracil—skin cancer	0.000233	0.000677	CcSEcCtD
Betaxolol—Thrombocytopenia—Docetaxel—skin cancer	0.000233	0.000676	CcSEcCtD
Betaxolol—Tachycardia—Docetaxel—skin cancer	0.000232	0.000674	CcSEcCtD
Betaxolol—Skin disorder—Docetaxel—skin cancer	0.000231	0.000671	CcSEcCtD
Betaxolol—Vomiting—Temozolomide—skin cancer	0.000228	0.00066	CcSEcCtD
Betaxolol—Anorexia—Docetaxel—skin cancer	0.000227	0.000658	CcSEcCtD
Betaxolol—Rash—Temozolomide—skin cancer	0.000226	0.000655	CcSEcCtD
Betaxolol—Diarrhoea—Fluorouracil—skin cancer	0.000226	0.000654	CcSEcCtD
Betaxolol—Dermatitis—Temozolomide—skin cancer	0.000226	0.000654	CcSEcCtD
Betaxolol—Headache—Temozolomide—skin cancer	0.000224	0.00065	CcSEcCtD
Betaxolol—Hypotension—Docetaxel—skin cancer	0.000222	0.000645	CcSEcCtD
Betaxolol—Dizziness—Fluorouracil—skin cancer	0.000218	0.000632	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000217	0.000629	CcSEcCtD
Betaxolol—Insomnia—Docetaxel—skin cancer	0.000215	0.000624	CcSEcCtD
Betaxolol—Paraesthesia—Docetaxel—skin cancer	0.000214	0.00062	CcSEcCtD
Betaxolol—Nausea—Temozolomide—skin cancer	0.000213	0.000617	CcSEcCtD
Betaxolol—Dyspnoea—Docetaxel—skin cancer	0.000212	0.000615	CcSEcCtD
Betaxolol—Vomiting—Fluorouracil—skin cancer	0.00021	0.000608	CcSEcCtD
Betaxolol—Dyspepsia—Docetaxel—skin cancer	0.00021	0.000608	CcSEcCtD
Betaxolol—Rash—Fluorouracil—skin cancer	0.000208	0.000603	CcSEcCtD
Betaxolol—Dermatitis—Fluorouracil—skin cancer	0.000208	0.000603	CcSEcCtD
Betaxolol—Decreased appetite—Docetaxel—skin cancer	0.000207	0.0006	CcSEcCtD
Betaxolol—Headache—Fluorouracil—skin cancer	0.000207	0.000599	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000206	0.000596	CcSEcCtD
Betaxolol—Fatigue—Docetaxel—skin cancer	0.000205	0.000595	CcSEcCtD
Betaxolol—Pain—Docetaxel—skin cancer	0.000204	0.00059	CcSEcCtD
Betaxolol—Constipation—Docetaxel—skin cancer	0.000204	0.00059	CcSEcCtD
Betaxolol—Feeling abnormal—Docetaxel—skin cancer	0.000196	0.000569	CcSEcCtD
Betaxolol—Nausea—Fluorouracil—skin cancer	0.000196	0.000568	CcSEcCtD
Betaxolol—Body temperature increased—Docetaxel—skin cancer	0.000188	0.000546	CcSEcCtD
Betaxolol—Hypersensitivity—Docetaxel—skin cancer	0.000175	0.000509	CcSEcCtD
Betaxolol—Asthenia—Docetaxel—skin cancer	0.000171	0.000495	CcSEcCtD
Betaxolol—Pruritus—Docetaxel—skin cancer	0.000168	0.000488	CcSEcCtD
Betaxolol—Diarrhoea—Docetaxel—skin cancer	0.000163	0.000472	CcSEcCtD
Betaxolol—Dizziness—Docetaxel—skin cancer	0.000157	0.000457	CcSEcCtD
Betaxolol—Vomiting—Docetaxel—skin cancer	0.000151	0.000439	CcSEcCtD
Betaxolol—Rash—Docetaxel—skin cancer	0.00015	0.000435	CcSEcCtD
Betaxolol—Dermatitis—Docetaxel—skin cancer	0.00015	0.000435	CcSEcCtD
Betaxolol—Headache—Docetaxel—skin cancer	0.000149	0.000432	CcSEcCtD
Betaxolol—Nausea—Docetaxel—skin cancer	0.000141	0.00041	CcSEcCtD
